Michael S. Aberman is VP at REGENERON PHARMACEUTICALS INC (REGN). They have made 3 open-market trades across 1 company since 2011, most recently 2017-06-22.
CIK 0000872589
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 3 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| REGN | 6,962 | $6.5M |
Shares reported on the most recent Form 4, priced at the 2017-06-23 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| REGN | SELL | 2017-06-22 | 2017-06-23 | $529.16 | $407K | -4.4% | +1.6% | -15.5% |
| REGN | SELL | 2017-06-22 | 2017-06-23 | $532.42 | $1.2M | -4.4% | +1.6% | -15.5% |
| REGN | SELL · 10b5-1 | 2015-03-24 | 2015-03-25 | $478.99 | $2.3M | -13.6% | -2.9% | -2.9% |
| REGN | SELL · 10b5-1 | 2015-03-18 | 2015-03-19 | $465.00 | $1.6M | -13.6% | -2.9% | -2.9% |
| REGN | SELL · 10b5-1 | 2015-02-24 | 2015-02-25 | $418.48 | $1.4M | -13.6% | -2.9% | -2.9% |
| REGN | SELL · 10b5-1 | 2015-02-17 | 2015-02-18 | $404.46 | $1.5M | -13.6% | -2.9% | -2.9% |
| REGN | SELL · 10b5-1 | 2014-08-19 | 2014-08-19 | $350.00 | $1.3M | -13.6% | -2.9% | -2.9% |
| REGN | SELL · 10b5-1 | 2014-02-18 | 2014-02-19 | $331.42 | $1.2M | -13.6% | -2.9% | -2.9% |
| REGN | SELL · 10b5-1 | 2013-05-14 | 2013-05-15 | $279.61 | $1.5M | -13.6% | -2.9% | -2.9% |
| REGN | SELL | 2013-05-06 | 2013-05-08 | $257.13 | $2.1M | -13.6% | -2.9% | -2.9% |
| REGN | SELL · 10b5-1 | 2012-12-11 | 2012-12-12 | $185.06 | $623K | -13.6% | -2.9% | -2.9% |
| REGN | SELL · 10b5-1 | 2012-11-30 | 2012-12-03 | $180.64 | $705K | -13.6% | -2.9% | -2.9% |
| REGN | SELL · 10b5-1 | 2012-05-01 | 2012-05-02 | $134.81 | $831K | -13.6% | -2.9% | -2.9% |
| REGN | SELL · 10b5-1 | 2011-09-02 | 2011-09-07 | $66.54 | $502K | -13.6% | -2.9% | -2.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.